Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
Resonance Contracted by Major Global Pharma Company for Clinical Drug Trial Worth $13.775 Million over 24 Months
nanoscience investing Sona Nanotech's THT Shows Potential in Preventing Tumor Formation and Recurrence
Heliostar Metals to Present at the Precious Metals & Critical Minerals Virtual Investor Conference October 14
